MedTrace Logo

Compliance With Once Daily Glaucoma Medication

NCT00333463 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2016-11-18

No results posted yet for this study

Summary

A study to examine patient compliance with once daily glaucoma medication

Conditions

  • Compliance

Interventions

BEHAVIORAL

Intervention

The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.

Sponsors & Collaborators

Principal Investigators

  • David Friedman, MD · Study Director

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00333463 on ClinicalTrials.gov